Yield10 Bioscience (YTENQ) Stock Statistics & Valuation Metrics

Yield10 Bioscience has a market cap or net worth of $1.00. The enterprise value is ―.

Yield10 Bioscience has 692,683 shares outstanding. The number of shares has decreased by -2.65% in one year.

Yield10 Bioscience’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Yield10 Bioscience is ―. Yield10 Bioscience’s PEG ratio is ―.

In the last 12 months, Yield10 Bioscience had revenue of ― and earned -14.46M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Yield10 Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Yield10 Bioscience upcoming earnings date is Aug 18, 2025, After Close (Confirmed).

Yield10 Bioscience as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Yield10 Bioscience has paid ― in taxes.

Yield10 Bioscience EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Yield10 Bioscience has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Yield10 Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is ―